A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients - Related Studies

A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients

This study has been completed.

Study NCT00000945. Last updated on July 29, 2008. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Immunologic Deficiency Syndromes
		Infection
		Leukoencephalopathy, Progressive Multifocal

3	More general conditions related to this trial
		Central Nervous System Diseases
		Central Nervous System Infections
		Central Nervous System Viral Diseases
		Demyelinating Diseases
		DNA Virus Infections
		Encephalitis
		Encephalitis, Viral
		Immune System Diseases
		Lentivirus Infections
		Nervous System Diseases
		Polyomavirus Infections
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		Cidofovir
		Probenecid

5	More general drug interventions related to this trial
		Anti-HIV Agents
		Anti-Infective Agents
		Anti-Retroviral Agents
		Antineoplastic Agents
		Antirheumatic Agents
		Antiviral Agents
		Gout Suppressants
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Renal Agents
		Therapeutic Uses
		Uricosuric Agents

6	Sponsors listed in this trial
		National Institute of Allergy and Infectious Diseases (NIAID)